The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review

C. Mortimer (Crawley, United Kingdom), D. Nikoletou (London, United Kingdom), A. Ooms (London, United Kingdom), J. Williams (Crawley, United Kingdom)

Source: Virtual Congress 2021 – Advances in asthma treatment
Session: Advances in asthma treatment
Session type: E-poster
Number: 3533

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Mortimer (Crawley, United Kingdom), D. Nikoletou (London, United Kingdom), A. Ooms (London, United Kingdom), J. Williams (Crawley, United Kingdom). The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review. 3533

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis
Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020
Year: 2021



Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Factors influencing the relative effect of leukotriene receptor antagonists (LTRA) and inhaled corticosteroids (ICS) as monotherapy in persistent asthma: A systematic review
Source: Annual Congress 2011 - Asthma management and response
Year: 2011


Comparison of the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013

Deprescribing montelukast in children with asthma: a systematic review
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


Medication use in COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007




Leukotriene receptor antagonists for allergic rhino-sinusitis: a systematic review and meta-analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 109s
Year: 2003

The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019

The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015


Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



ICS-formoterol reliever versus ICS and short-acting ß2-agonist reliever in asthma: a systematic review and meta-analysis
Source: ERJ Open Res, 7 (1) 00701-2020; 10.1183/23120541.00701-2020
Year: 2021



Evaluating inhaled corticosteroid use among pregnant women with asthma: systematic review and meta-analysis
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Intravenous theophylline levels in children with acute asthma: A systematic review
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016

A systematic review of the use of physiological tests assessing the acute response to treatment during exacerbations of COPD
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Clinical review of long-term pranlukast therapy in adult patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 310s
Year: 2004

Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016


Short-acting bronchodilator reversibility does not predict the response to long-term treatment by indacaterol 150 µg in COPD: REVERBREZ study
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013